ABSTRACT: The purpose of this study was to assess whether different stages of chronic obstructive pulmonary disease (COPD) severity de ned according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria correlate with meaningful differences in health status.
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has recently released a four-stage classi cation of chronic obstructive pulmonary disease (COPD) severity to guide the therapeutic approach [1] . In these patients, stage 0 de nes the condition characterised by classic clinical symptoms but normal spirometry. Stage I de nes patients with a forced expiratory volume in one second (FEV1)/forced vital capacity (FVC) of <70%, and an FEV1 of >80% predicted, with or without chronic symptoms that may or may not be aware of disease status. Stage II (FEV1/FVC <70%, FEV1 30-79%) is split into substages IIa (FEV1 50-79%) and IIb (FEV1 30-49%) according to the greater rate of exacerbation experienced by patients in substage IIb, which in turn is inversely related to health status [2] . Finally, stage III (FEV1/ FVC <70% and either FEV1 <30% pred, hypoxaemia, or clinical signs of right heart failure) is expected to be associated with the worst health status.
However, the GOLD guidelines do not clearly de ne the rationale supporting the suggested classi cation scheme. Previous experience shows that worsening health status only re ects increased COPD severity categorised on the basis of FEV1 % pred, to a limited extent. Instead, comorbidity plays an important role in de ning health status, mainly in mild-tomoderate COPD [3] . The Salute Respiratoria nell9Anziano: Respiratory Health in the Elderly (SaRA) study provides a unique opportunity of verifying whether and to what extent GOLD stages of COPD severity correlate with health status.
The availability of disease-speci c indexes of health status and of indexes of performance allows detection of the differences between stages. Thus, the present analysis has been performed to test the discriminatory capacity of the GOLD staging system versus health status.
Methods
A detailed description of the SaRA study is available elsewhere [4, 5] . Brie y, the SaRA study aims to de ne the relationship between disease severity and health status and its main determinants in a population aged >64 yrs with chronic respiratory problems. In the present study, 381 patients with a de nite diagnosis of COPD or nonobstructive bronchitis were classi ed according to GOLD stages of COPD severity. A diagnosis of nonobstructive bronchitis, corresponding to GOLD stage 0, was made if patients complained of cough and sputum for " 3 months?yr -1 for " 2 yrs consecutively (Chemical Industries Barel (CIBA) criteria), but had normal spirometry.
Patients were considered to be affected by COPD if they ful lled either of the following criteria: 1) they met the CIBA criteria, had an FEV1/FVC of<70% pred and no change or an FEV1 increase of >12%, but not FEV1 normalisation after 100 mg fenoterol; or 2) they neither met the CIBA criteria nor reported history of wheeze in the last year, had an FEV1/FVC of <70% pred, an FEV1 of <80% pred and an FEV1 increase of <12% after 100 mg fenoterol.
A diagnosis of asthma was made if patients did not meet the CIBA criteria and had either of the following: 1) an FEV1 of >80% pred and a history of wheeze in the last year; 2) an FEV1 of <80% pred, an FEV1 increase of >12% after 100 mg fenoterol and a history of wheeze in the last year; or 3) an FEV1 of <80% pred, an FEV1 increase of >12% after 100 mg fenoterol and no history of wheeze in the last year. Asthmatics were excluded from the study.
Health status was measured using disease-speci c indexes ("Symptoms", "Activity" and "Impacts" components and "Total" score of the St George Respiratory Questionnaire (SGRQ)) and generic indexes assessing cognitive performance (Mini Mental Status Examination (MMSE)), affective performance (15-item Geriatric Depression Scale (15-GDS)), physical performance (Barthel9s index, 6-min walking test) and quality of sleep (index of disturbed sleep from the Established Populations for Epidemiologic Studies of the Elderly questionnaire (EPESE)), respectively [6] [7] [8] [9] [10] [11] [12] . The 6-min walking distance is expressed as per cent of the predicted based on age, sex, height and weight (WT % pred) [13] . The meanings of individual indexes and information on their validity in older COPD patients are presented in table 1 .
Differences in health status indexes among groups were assessed as follows.
1) Multivariate analysis of covariance (MANCOVA) for indexes with both normal distribution and homogeneous variance: MMSE, WT % pred, SGRQ Impacts, SGRQ Total, EPESE. The effects of three factors (GOLD stage, sex, living conditions (alone, with relatives/others)) and four covariates previously proven (waist:hip ratio, occiput-wall distance, number of comorbid diseases) or the likelihood of affecting the health status in COPD (age) were also assessed [3, 14] . The Wilk9s lambda coef cient was computed to quantify the effects of individual factors and their effect on health status. The contribution of individual covariates toward an explanation of the distribution of the dependent variables was expressed by the respective F value. For each dependent variable, a multiple regression versus all the covariates was also performed and the b coef cient was assumed as a measure of the relationship between the dependent variable and the corresponding covariate. Post hoc differences between stages were assessed by the Scheffè test.
2) Kruskal Wallis test for indexes lacking normal distribution and/or homogeneous variance: 15-GDS, Barthel9s index, SGRQ Symptoms and Activity. Differences between stages were assessed using the Mann-Whitney U-test.
The linear regression analysis was performed to assess the relationship between SGRQ Total and airway obstruction, as expressed by FEV1 %.
Results
The general characteristics of patients are summarised in table 2. A geriatric and poorly educated population was used in this study, a minority of which continued to smoke. About one in four patients was female and one in ve lived alone. The average occiput-wall distance of 6.6 cm indirectly testi es that osteoporosis was a common problem. The average nutritional status expressed by the body mass index, was normal, whereas the relatively high waist:hip ratio was consistent with a prevalently visceral distribution of fat. Most of the drugs used were intended for nonrespiratory problems. Cardiovascular diseases, diabetes mellitus, visual and hearing impairment were the most common comorbid conditions.
The demographical characteristics and respiratory function indexes of patients grouped according to GOLD stages are reported in table 3. Stages had comparable age and proportion of patients living alone, whereas the prevalence of females was higher in stages 0-IIA. According to classi cation criteria, both FEV1 % and FEV1/FVC were normal in GOLD stage 0.
MANCOVA results are reported in table 4. Increasing Comorbidity was associated with a higher EPESE score, i.e. with worse quality of sleep (b=0.175, p<0.01) and higher Impacts (b=0.137, p=0.02) and Total (b=0.115, p=0.05) SGRQ scores. Age was associated with higher Total SGRQ score (b=0.136, p=0.02) .
Post-hoc analysis of differences between GOLD stages showed important differences in both SGRQ Impacts and Total between nonconsecutive stages but only between IIa and IIb consecutive stages.
The differences among GOLD stages in health status indexes assessed by the Kruskal Wallis test are reported in table 6. Both SGRQ Symptoms and Impacts worsened from stage 0 to stage III, but the only consecutive stages signicantly differing in these indexes were IIa and III. Variability in health status scores was very high: 23% of stage 0 and 25.5% of stage I patients scored >64, which correspond to the average score of patients in stage IIb, on the SGRQ Symptoms. 
Discussion
The present results demonstrate that the GOLD staging system marks important differences in health status assessed by a disease-speci c index or the Barthel index. The age of the patients may explain why the Barthel9s index but not the WT % pred could distinguish between groups, as the elderly are exposed to the negative impact of disabling conditions mainly on the basic and instrumental activities of daily living. Accordingly, a test assessing submaximal physical performance is expected to lose part of its discriminatory capacity in an elderly population. Indexes of affective status and quality of sleep could not distinguish GOLD stages, although depression and disturbed sleep are common COPD-related problems. Indeed, depression and sleep problems seem to complicate COPD in its earliest stage but, at variance from physical limitations, their prevalence and severity do not parallel increasing COPD severity. The relatively low size of the stage III population, i.e. of patients most exposed to the risk of cognitive impairment, may explain why MMSE also failed to distinguish GOLD stages.
The present ndings have been obtained in a rigorously selected population and corrected for the confounding effect of several variables proven or supposed to affect the health status. Thus, they demonstrate that GOLD staging of COPD corresponds to important differences in health status between stages IIa and IIb, but not between other consecutive stages. This suggests that the boundary between stages IIa and IIb marks a turning point in the evolution of health status in COPD patients. In contrast, no signi cant change in health status marks the earliest progression of COPD from stage 0 to I and from I to IIa, as well as its ultimate transition from stage IIb to III. The size inequality of groups IIb and III and the consistent overlapping of health status scores recorded in consecutive stages are likely to explain these ndings.
An index of airway obstruction accounted for a minority of the explained variance in SGRQ Total score. This nding and the great interindividual variability in health status within a given GOLD stage clearly shows that health status cannot be inferred from the GOLD stage and should be systematically assessed in the individual patient. It would appear that a disease-speci c instrument is recommended due to its superior discriminatory capacity. However, a generic index of physical capability, such as the Barthel9s index, can represent a valuable alternative because it requires very little time and allows comparison between patients with different main diseases.
The observed greater susceptibility of females to the negative effects of COPD on the health status represents an original nding. Indeed, the authors could nd only one report showing that female sex weakens the positive effects of rehabilitation on disease-related health status in COPD [15] . A similar sex effect has been reported for cardiovascular rehabilitation programmes [16] . Whatever its determinants, the observed phenomenon deserves special consideration. Indeed, females represent a rapidly increasing proportion of all COPD patients, as can be inferred from the dramatically rising prevalence of cigarette smoking among females, as well as from the greater impact of smoke on lung function of females [17, 18] . Furthermore, COPD will become the fth leading cause of disability in af uent countries by year 2020 [19] . The dramatic rise in the prevalence of female patients is hypothesised to result in a greater than expected effect of COPD on the health status and, as a consequence, the need of care.
Patients classi ed in the 0 and I GOLD stages have an FEV1 of >80% pred and, thus, are excluded from previous classi cations of COPD severity [20] [21] [22] . This prevents any comparison of health status classi cations achieved by GOLD and previous staging systems. Nevertheless, the nding that about one of four patients in GOLD stage 0 scored higher than the average patient in GOLD stage IIb suggests that health status frequently deteriorates even in the absence of bronchial obstruction, possibly because of respiratory symptoms or coexisting nonrespiratory problems. The impact of comorbidity on selected measures of health status in this and in a previous study supports the latter hypothesis [3] .
The limitations of this study deserve to be discussed. First, survival bias might have attenuated the differences between the most severe stages. Only a longitudinal study can test this hypothesis. Secondly, the lack of statistically signi cant differences between consecutive stages other than IIa and IIb does not guarantee that clinically signi cant differences were absent. Indeed, stages I and IIa, as well as stages IIb and III, differed in SGRQ Total score by six and 12 points, respectively, i.e. of a magnitude well over the clinically relevant minimal difference of four [6] . These differences might qualify as statistically signi cant in a larger population. Finally, distinguishing long-standing asthma from COPD is quite problematic in the elderly [23] . The authors9 diagnostic criteria were carefully developed and rigorously applied but could not guarantee the absence of occasional misclassi cations.
In conclusion, ndings from this study show that staging chronic obstructive pulmonary disease according to Global Initiative for Chronic Obstructive Lung Disease guidelines does correspond to important differences in health status, but that health status patterns of consecutive stages overlap remarkably. Further research is needed to verify whether integrating the Global Initiative for Chronic Obstructive Lung Disease stage with selected measures of health status will allow de nition of subgroups with a distinctive prognosis. Special attention should be paid to the heterogeneity of health status in stages 0 and 1: selected health status patterns might be a marker of chronic obstructive pulmonary disease progression rate. Prospectively assessing these topics will improve knowledge of the Global Initiative for Chronic Obstructive Lung Disease classi catory and prognostic implications, as well as of the feasibility of a mixed, i.e. physiopathologicalclinical and health-status indicator based, chronic obstructive pulmonary disease staging system. Finally, the important differences in health status between stages IIa and IIb and the lack of signi cant differences between lower grade consecutive stages suggests that every effort should be made to prevent the progression of chronic obstructive pulmonary disease, since passing the boundary of a forced expiratory volume in one second of <50% of predicted is likely to herald a dramatic decline of the health status.
